| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 03/01/2025 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:GRTS | Gritstone bio Inc |
| 10/10/2024 | 11:50 | Business Wire | Gritstone bio Takes Action to Preserve Value and Strengthen Capital Structure | NASDAQ:GRTS | Gritstone bio Inc |
| 07/10/2024 | 23:01 | Edgar (US Regulatory) | Form SC 13G - Statement of Beneficial Ownership by Certain Investors | NASDAQ:GRTS | Gritstone bio Inc |
| 13/08/2024 | 22:10 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:GRTS | Gritstone bio Inc |
| 13/08/2024 | 22:05 | GlobeNewswire Inc. | Gritstone bio Reports Second Quarter 2024 Financial Results and Provides Corporate Updates | NASDAQ:GRTS | Gritstone bio Inc |
| 05/08/2024 | 11:45 | PR Newswire (US) | Lost Money on Gritstone bio, Inc. (GRTS)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm | NASDAQ:GRTS | Gritstone bio Inc |
| 05/08/2024 | 11:45 | PR Newswire (US) | Lost Money on Gritstone bio, Inc.(GRTS)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm | NASDAQ:GRTS | Gritstone bio Inc |
| 25/07/2024 | 11:45 | PR Newswire (US) | Gritstone bio, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before August 6, 2024 to Discuss Your Rights - GRTS | NASDAQ:GRTS | Gritstone bio Inc |
| 25/07/2024 | 08:38 | PR Newswire (US) | Gritstone Bio Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GRTS | NASDAQ:GRTS | Gritstone bio Inc |
| 24/07/2024 | 13:00 | GlobeNewswire Inc. | Gritstone bio to Host Virtual KOL Event to Discuss Unmet Need and Potential Role of Its Personalized Cancer Vaccine, GRANITE, in Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) | NASDAQ:GRTS | Gritstone bio Inc |
| 17/07/2024 | 11:45 | PR Newswire (US) | The Gross Law Firm Notifies Shareholders of Gritstone bio, Inc.(GRTS) of a Class Action Lawsuit and an Upcoming Deadline | NASDAQ:GRTS | Gritstone bio Inc |
| 10/07/2024 | 13:00 | GlobeNewswire Inc. | Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NASDAQ:GRTS | Gritstone bio Inc |
| 03/07/2024 | 11:45 | PR Newswire (US) | Gritstone bio, Inc. Class Action: The Gross Law Firm Reminds Gritstone Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 6, 2024 - GRTS | NASDAQ:GRTS | Gritstone bio Inc |
| 25/06/2024 | 11:45 | PR Newswire (US) | Shareholders that lost money on Gritstone bio, Inc.(GRTS) should contact The Gross Law Firm about pending Class Action - GRTS | NASDAQ:GRTS | Gritstone bio Inc |
| 20/06/2024 | 11:45 | PR Newswire (US) | Shareholders that lost money on Gritstone bio, Inc.(GRTS) Urged to Join Class Action - Contact The Gross Law Firm to Learn More | NASDAQ:GRTS | Gritstone bio Inc |
| 17/06/2024 | 11:45 | PR Newswire (US) | The Gross Law Firm Reminds Gritstone bio, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 6, 2024 - GRTS | NASDAQ:GRTS | Gritstone bio Inc |
| 04/06/2024 | 22:05 | GlobeNewswire Inc. | Gritstone bio to Participate in Upcoming Investor and Scientific Conferences | NASDAQ:GRTS | Gritstone bio Inc |
| 18/05/2024 | 03:57 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:GRTS | Gritstone bio Inc |
| 10/05/2024 | 22:06 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:GRTS | Gritstone bio Inc |
| 09/05/2024 | 22:05 | GlobeNewswire Inc. | Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates | NASDAQ:GRTS | Gritstone bio Inc |
| 02/05/2024 | 22:05 | GlobeNewswire Inc. | Gritstone bio to Report First Quarter 2024 Financial Results and Provide Corporate Updates on May 9, 2024 | NASDAQ:GRTS | Gritstone bio Inc |
| 30/04/2024 | 13:00 | GlobeNewswire Inc. | Gritstone bio Highlights the Durability and Potential Broad Utility of its Self-amplifying mRNA (samRNA) COVID-19 Vaccine at ESCMID Global 2024 | NASDAQ:GRTS | Gritstone bio Inc |
| 29/04/2024 | 13:00 | GlobeNewswire Inc. | Gritstone bio Announces Appointment of Stephen Webster to its Board of Directors | NASDAQ:GRTS | Gritstone bio Inc |
| 15/04/2024 | 13:00 | GlobeNewswire Inc. | Nature Medicine Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of “Off-the-Shelf” Neoantigen Vaccine Platform (SLATE) | NASDAQ:GRTS | Gritstone bio Inc |
| 08/04/2024 | 13:00 | GlobeNewswire Inc. | Gritstone bio Presents Improvements to EDGE™ Platform at AACR 2024 | NASDAQ:GRTS | Gritstone bio Inc |
| 02/04/2024 | 05:00 | GlobeNewswire Inc. | Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering | NASDAQ:GRTS | Gritstone bio Inc |
| 01/04/2024 | 22:10 | GlobeNewswire Inc. | Gritstone bio Announces Proposed Public Offering | NASDAQ:GRTS | Gritstone bio Inc |
| 01/04/2024 | 22:01 | GlobeNewswire Inc. | Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite Sta | NASDAQ:GRTS | Gritstone bio Inc |
| 05/03/2024 | 22:39 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:GRTS | Gritstone bio Inc |
| 05/03/2024 | 22:05 | GlobeNewswire Inc. | Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates | NASDAQ:GRTS | Gritstone bio Inc |
